Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0001415889-24-013504 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-17 | 2024-05-15+ | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale+OE | $42.30 | -30.8K | 53.2K | -37% | -$1.30M |
| DM | 2024-05-17 | 2024-05-15+ | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $6.75 | +28.9K | 61.4K | +89% | +$194.9K |
| DM | 2024-05-17 | 2024-05-15+ | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $0.00 | -28.9K | 69.3K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-16 | S | D | 18,151 | $42.22 | 51,206 | D | — | — | (F1) The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.86, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2024-05-16 | S | D | 2,500 | $43.03 | 51,206 | D | — | — | (F2) The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.08, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2024-05-16 | M | A | 2,500 | $7.87 | 53,706 | D | — | — | |
| 4 | Common | Class A Common Stock | 2024-05-16 | M | A | 18,151 | $7.87 | 69,357 | D | — | — | |
| 5 | Common | Class A Common Stock | 2024-05-15 | S | D | 1,965 | $42.68 | 51,206 | D | — | — | |
| 6 | Common | Class A Common Stock | 2024-05-15 | S | D | 8,221 | $42.17 | 53,171 | D | — | — | |
| 7 | Common | Class A Common Stock | 2024-05-15 | M | A | 8,221 | $3.94 | 61,392 | D | — | — | |
| 8 | Derivative | Stock Option (right to buy) | 2024-05-15 | M | D | 8,221 | $0.00 | 58,589 | D | $3.94 · — to 2031-04-13 | 8,221 Class A Common Stock | (F3) 1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter. |
| 9 | Derivative | Stock Option (right to buy) | 2024-05-16 | M | D | 20,651 | $0.00 | 69,349 | D | $7.87 · — to 2033-02-14 | 20,651 Class A Common Stock | (F4) 1/48 of the total stock option vests and becomes exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date. |